CHNA
Loncar China BioPharma ETF
CHNA
CHNA
Delisted
CHNA was delisted on the 20th of October, 2023.
7 hedge funds and large institutions have $2.14M invested in Loncar China BioPharma ETF in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$346K |
| 2 |
FEM
Fulcrum Equity Management
Plano,
Texas
|
+$16.9K |
| 3 |
WEC
Winslow Evans & Crocker
Boston,
Massachusetts
|
+$15K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.12K |
Top Sellers
| 1 |
Jane Street
New York
|
-$237K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$16.5K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $1.35M | -$237K | -7,275 | -15% |
|
|
2
Citadel Advisors
Miami,
Florida
| $346K | +$346K | +10,621 | New |
|
|
FEM
3
Fulcrum Equity Management
Plano,
Texas
| $326K | +$16.9K | +519 | +5% |
|
4
Morgan Stanley
New York
| $65K | – | – | – |
|
|
5
Osaic Holdings
Scottsdale,
Arizona
| $23K | +$1.12K | +35 | +5% |
|
|
WEC
6
Winslow Evans & Crocker
Boston,
Massachusetts
| $15K | +$15K | +470 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $13K | -$16.5K | -494 | -56% |
|